Journal of the American Chemical Society
ARTICLE
’ AUTHOR INFORMATION
(6) Movassaghi, M.; Schmidt, M. A.; Ashenhurst, J. A. Org. Lett.
2008, 10, 4009–4012.
Corresponding Author
movassag@mit.edu; scott.miller@yale.edu
(7) For selected reviews and recent advances, see:(a) Johnson, R. A.;
Sharpless, K. B. In Comprehensive Organic Synthesis; Trost, B. M., Ed.;
Pergamon: New York, 1991; Vol. 7, p 389. (b) Jacobsen, E. N.; Wu, M. H. In
Comprehensive Asymmetric Catalysis II; Jacobsen, E. N., Pfaltz, A., Yamamoto,
H., Eds.; Springer-Verlag: Berlin, 1999; p 649. (c) Aggarwal, V. K.; Winn,
C. L. Acc. Chem. Res. 2004, 37, 611–620. (d)Xia, Q. H.;Ge, H. Q.;Liu, Z. M.;
Su, K. X. Chem. Rev. 2005, 105, 1603–1662. (e) Kelly, D. R.; Roberts, S. M.
Biopolymers 2006, 84, 74–89. (f) Berkessel, A.; Koch, B.; Toniolo, C.;
Rainaldi, M.; Broxterman, Q. B.; Kaptein, B. Biopolymers 2006, 84, 90–96.
(g) Wong, O. A.; Shi, Y. Chem. Rev. 2008, 108, 3958–3987. (h) Li, Z.; Zhang,
W.; Yamamoto, H. Angew. Chem., Int. Ed. 2008, 47, 7520–7522.
(8) For an interesting and promising example, see ref 4q.
(9) (a) Taniguchi, M.; Anjiki, T.; Nakagawa, M.; Hino, T. Chem.
Pharm. Bull. 1984, 32, 2544–2554. (b) Berrier, C.; Jacquesy, J. C.;
Jouannetaud, M. P.; Renoux, A. New J. Chem. 1987, 11, 611–615. (c)
Duflos, A.; Redoules, F.; Fahy, J.; Jacquesy, J.; Jouannetaud, M. J. Nat.
Prod. 2001, 64, 193–195. (d) Lakatosh, S. A.; Balzarini, J.; Andrei, G.;
Snoeck, R.; De Clercq, E.; Preobrazhenskaya, M. N. J. Antibiot. 2002,
55, 768–773. (e) Beyer, M.; Fritscher, J.; Feresin, E.; Schiemann, O.
J. Org. Chem. 2003, 68, 2209–2215.
’ ACKNOWLEDGMENT
This work is supported by National Institutes of Health,
National Institute of General Medical Sciences (GM096403 to
S.J.M. and GM089732 to M.M.). M.M. also thanks Amgen and
DuPont for additional financial support. M.M., M.N.N., and
M.T. thank Dr. Cristina M. Nieto-Oberhuber and Ms. Yuki
Nakamura in the Movassaghi group for helpful discussions.
’ REFERENCES
(1) (a) Williams, R. M.; Kwast, E.; Coffman, H.; Glinka, T. J. Am.
Chem. Soc. 1989, 111, 3064–3065. (b) Sanz-Cervera, J. F.; Glinka, T.;
Williams, R. M. Tetrahedron 1993, 49, 8471–8482. (c) Schmidt, M. A.;
Movassaghi, M. Synlett 2008, 3, 313–324.
(2) Williams, R. M.; Stocking, E. M.; Sanz-Cervera, J. F. In Biosynth-
esis: Aromatic Polyketides, Isoprenoids, Alkaloids; Topics in Current
Chemistry; Leeper, F. J., Vederas, J. C., Eds.; Springer: Berlin, 2000.
(3) (a) Schkeryantz, J. M.; Woo, J. C. G.; Siliphaivanh, P.; Depew,
K. M.; Danishefsky, S. J. J. Am. Chem. Soc. 1999, 121, 11964–11975. (b)
Wang, H.; Ganesan, A. J. Org. Chem. 2000, 65, 4685–4693. (c) Baran,
P. S.; Corey, E. J. J. Am. Chem. Soc. 2002, 124, 7904–7905. (d) Marti, C.;
Carreira, E. M. Eur. J. Org. Chem. 2003, 12, 2209–2219. (e) Williams,
R. M.; Cox, R. J. Acc. Chem. Res. 2003, 36, 127–139.
(10) Peris, G.; Jakobsche, C. E.; Miller, S. J. J. Am. Chem. Soc. 2007,
129, 8710–8711.
(11) (a) Greene, F. D.; Kazan, J. J. Org. Chem. 1963, 28, 2168–2171.
(b) Rebek, J.; McCready, R.; Wolf, S.; Mossman, A. J. Org. Chem. 1979,
44, 1485–1493. (c) Spantulescu, M. D.; Jain, R. P.; Derksen, D. J.;
Vederas, J. C. Org. Lett. 2003, 5, 2963–2965.
(12) Jakobsche, C. E.; Peris, G.; Miller, S. J. Angew. Chem., Int. Ed.
2008, 47, 6707–6711.
(4) For representative examples of the utility of hydroxyindolenine
intermediates in complex synthesis, see:(a) Finch, N.; Taylor, W. I.
J. Am. Chem. Soc. 1962, 84, 3871. (b) Finch, N.; Gemenden, C. W.; Hsu,
I. H.; Kerr, A.; Sim, G. A.; Taylor, W. I. J. Am. Chem. Soc. 1965,
87, 2229–2235. (c) Hutchison, A. J.; Kishi, Y. J. Am. Chem. Soc. 1979,
101, 6786–6788. (d) Williams, R. M.; Glinka, T.; Kwast, E.; Coffman,
H.; Stille, J. K. J. Am. Chem. Soc. 1990, 112, 808–821. (e) Jossang, A.;
Jossand, P.; Hadi, H. A.; Sevenet, T.; Bodo, B. J. Org. Chem. 1991,
56, 6527–6530. (f) Gueller, R.; Borschberg, H. Helv. Chim. Acta 1993,
76, 1847–1862. (g) Stoermer, D.; Heathcock, C. H. J. Org. Chem. 1993,
58, 564–568. (h) Gueller, R.; Borschberg, H. Tetrahedron Lett. 1994,
35, 865–868. (i) Cushing, T. D.; Sanz-Cervera, J. F.; Williams, R. M.
J. Am. Chem. Soc. 1996, 118, 557–579. (j) Takayama, H.; Kurihara, M.;
Subhadhirasakul, S.; Kitajima, M.; Aimi, N.; Sakai, S. Heterocycles 1996,
42, 87–92. (k) Ito, M.; Clark, C. W.; Mortimore, M.; Goh, J. B.; Martin,
S. F. J. Am. Chem. Soc. 2001, 123, 8003. (l) Baran, P. S.; Corey, E. J. J. Am.
Chem. Soc. 2002, 124, 7904–7905. (m) Williams, R. M.; Cox, R. J. Acc.
Chem. Res. 2003, 36, 127and references cited therein. (n) Liu, Y.;
McWhorter, W. W., Jr.; Hadden, C. E. Org. Lett. 2003, 5, 333–335.
(o) Baran, P. S.; Richter, J. M. J. Am. Chem. Soc. 2005, 127,
15394–15396. (p) Poriel, C.; Lachia, M.; Wilson, C.; Davies, J. R.;
Moody, C. J. J. Org. Chem. 2007, 72, 2978–2987. (q) Pettersson, M.;
Knueppel, D.; Martin, S. F. Org. Lett. 2007, 9, 4623–4626. (r) Miller,
K. A.; Tsukamoto, S.; Williams, R. M. Nature Chem. 2009, 1, 63–68.
(5) For examples of aryl migration, see:(a) Witkop, B.; Ek, A. J. Am.
Chem. Soc. 1951, 73, 5664–5669. (b) Evans, F. J.; Lyle, G. G.; Watkins, J.;
Lyle, R. E. J. Org. Chem. 1962, 27, 1553–1557. (c) Hishmat, O. H.;
Abd-El Rahman, A. H.; El-Ebrashi, N. M. A.; Ishmail, M. M. F. Chem. Ind.
1986, 4, 142–143. (d) Liu, Y.; McWhorter, W. W., Jr. J. Org. Chem. 2003,
68, 2618–2622. For key related studies, see:(e) Witkop, B.; Patrick, J. B.
J. Am. Chem. Soc. 1951, 2188–2195. (f) Acheson, R. M.; Snaith, R. W.;
Vernon, J. M. J. Chem. Soc. 1964, 3229–3223. (g) Walser, A.; Blount,
J. F.; Fryer, R. I. J. Org. Chem. 1973, 38, 3077–3084. (h) Wenkert, E.; Shi,
Y. Synth. Commun. 1989, 19, 1071–1079. (i) Zhang, X.; Foote, C. S.
J. Am. Chem. Soc. 1993, 115, 8867–8868. (j) Tany, M.; Matsumoto, S.;
Aida, Y.; Arikawa, S.; Nakane, A.; Yokoyama, Y.; Murakami, Y. Chem.
Pharm. Bull. 1994, 42, 443–453. (k) Lachia, M.; Poriel, C.; Slawin,
A. M. Z.; Moody, C. J. Chem. Commun. 2007, 286–288. (l) Lindel, T.;
Br€auchle, L.; Golz, G.; B€ohrer, P. Org. Lett. 2007, 9, 283–286.
(13) (a) Takagi, J.; Sato, K.; Hartwig, J. F.; Ishiyama, T.; Miyaura, N.
Tetrahedron Lett. 2002, 43, 5649–5651. (b) Ishiyama, T.; Takagi, J.;
Nobuta, Y.; Miyaura, N. Org. Synth. 2005, 82, 126–131.
(14) (a) Billingsley, K.; Buchwald, S. L. J. Am. Chem. Soc. 2007,
129, 3358–3366.(b) See also ref 6.
(15) Synthesis details may be found in the Supporting Information.
(16) Astolphi, P.; Greci, L.; Rizzoli, C.; Sgarabotto, P.; Marrosu, G.
J. Chem. Soc. Perkin Trans. 2, 2001, 1634–1640.
(17) (a) Majetich, G.; Hicks, R. Synlett 1996, 649–651. (b) Murray,
R. W.; Iyanar, K. J. Org. Chem. 1998, 63, 1730–1731. (c) Majetich, G.;
Hicks, R.; Sun, G.; McGill, P. J. Org. Chem. 1998, 63, 2564–2573.
(18) (a) Lewis, C. A.; Miller, S. J. Angew. Chem., Int. Ed. 2006, 45, 5616–
5619. (b) Balskus, E. P.; Jacobsen, E. N. Science 2007, 317, 1736–1740.
(19) Masamune, S.; Choy, W.; Petersen, J. S.; Sita, L. R. Angew.
Chem., Int. Ed. 1985, 24, 1–76.
(20) (a) Rose, G. D.; Gierasch, L. M.; Smith, J. A. Adv. Protein Chem.
1985, 37, 1–109. (b) Haque, T. S.; Little, J. C.; Gellman, S. H. J. Am. Chem.
Soc. 1996, 118, 6975–6985. (c) Miller, S. J. Acc. Chem. Res. 2004, 37, 601–610.
(21) (a) Kametani, T.; Kanaya, N.; Ihara, M. J. Am. Chem. Soc. 1980,
102, 3974–3975. (b) Plate, R.; Akkerman, M. A. J.; Ottenheijm, H. C. J.
J. Chem. Soc., Perkin Trans. 1 1987, 2481–2490. (c) Sanz-Cervera, J. F.;
Glinka, T.; Williams, R. M. Tetrahedron 1993, 49, 8471–8482. (d)
Schkeryantz, J. M.; Woo, J. C. G.; Siliphaivanh, P.; Depew, K. M.;
Danishefsky, S. J. J. Am. Chem. Soc. 1999, 121, 11964–11975.
(22) The stereochemical assignments for the products are discussed
below and in the Supporting Information.
(23) Catalytic reactions involving substrate 25 have been performed
on up to 770 mg (2 mmol) of the substrate with excellent consistency
and reproducibility.
(24) Calculations at the B3LYP/6-31G(d) suggests the HOMO
of (N-phthalimido)-2-phenyltryptamine is higher than that of
(N-phthalimido)-tryptamine by 2.9 kcal/mol.
(25) Substrates 40a,b were prepared by deprotection of compound
40c followed by amine acylation or sulfonylation.
(26) Oxidation of 2,3-dimethylindole and 3-(2-N,N-phthaloyl-
aminoethyl)-2-(3-oxobutyl)-1H-indole under the standard conditions deli-
vers the corresponding over-oxidation products. See Supporting Information.
9111
dx.doi.org/10.1021/ja202706g |J. Am. Chem. Soc. 2011, 133, 9104–9111